Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
68.8M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
7.7M
-
Shares change
-
+7.7M
-
Total reported value, excl. options
-
$50.7M
-
Value change
-
+$50.7M
-
Number of buys
-
31
-
Price
-
$6.58
Significant Holders of EyePoint Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (EYPT) as of Q4 2020
33 filings reported holding EYPT - EyePoint Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q4 2020.
EyePoint Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (EYPT) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.7M shares
of 68.8M outstanding shares and own 11.19% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (4.19M shares), FRANKLIN RESOURCES INC (1.41M shares), Logos Global Management LP (700K shares), HighTower Advisors, LLC (528K shares), VANGUARD GROUP INC (322K shares), GSA CAPITAL PARTNERS LLP (104K shares), BlackRock Inc. (101K shares), GEODE CAPITAL MANAGEMENT, LLC (58.4K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (53.9K shares), and JACOBS LEVY EQUITY MANAGEMENT, INC (28.3K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.